Clinical Trials Browser

Completed × Prostatic Neoplasms × tetrathiomolybdate × Clear all

NCT00150995 2015-01-21

Tetrathiomolybdate in Hormone Refractory Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms